TruScreen Group Limited (NZE:TRU)

New Zealand flag New Zealand · Delayed Price · Currency is NZD
0.0200
0.00 (0.00%)
At close: Feb 20, 2026
Market Cap14.95M -3.4%
Revenue (ttm)1.82M -32.0%
Net Income-2.47M
EPS-0.00
Shares Out747.33M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,145,212
Average Volume742,273
Open0.0200
Previous Close0.0200
Day's Range0.0200 - 0.0200
52-Week Range0.0160 - 0.0370
Beta-0.13
RSI54.70
Earnings DateFeb 27, 2026

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in... [Read more]

Sector Healthcare
Founded 2013
Country New Zealand
Stock Exchange New Zealand Stock Exchange
Ticker Symbol TRU
Full Company Profile

Financial Performance

In fiscal year 2025, TruScreen Group's revenue was 2.07 million, a decrease of -20.28% compared to the previous year's 2.60 million. Losses were -2.24 million, 9.41% more than in 2024.

Financial Statements